Symmetric lipophilic polyamines exhibiting antitumor activity.

Ksenia A Perevoshchikova, Elizaveta A Eshtukova-Shcheglova, Oleg V Markov, Andrey V Markov, Ivan V Chernikov, Mikhail A Maslov, Marina A Zenkova

Bioorganic & medicinal chemistry 2022 Dec 15

filter terms:

Unsymmetric lipophilic polyamine derivatives are considered as potential antitumor agents. Here, a series of novel symmetric lipophilic polyamines (LPAs) based on norspermine and triethylenetetramine (TETA) backbones bearing alkyl substituents with different lengths (from decyl to octadecyl) at C(1) atom of glycerol were synthesized. Performed screening of the cytotoxicity of novel compounds on the panel of tumor cell lines (MCF-7, KB-3-1, B16) and non-malignant fibroblasts hFF3 in vitro revealed a correlation between the length of the aliphatic moieties in LPAs and their toxic effects - LPAs with the shortest decyl substituent were found to exhibit the highest cytotoxicity. Furthermore, norspermine-based LPAs displayed somewhat more pronounced cytotoxicity compared with their TETA-based counterparts. Further mechanistic studies demonstrated that hit LPAs containing the norspermine backbone and tetradecyl or decyl substituents efficiently induced apoptosis in KB-3-1 cells. Moreover, decyl-bearing LPA inhibited motility and enhanced adhesiveness of murine B16 melanoma cells in vitro, showing promising antimetastatic potential. Thus, developed novel symmetric norspermine-based LPAs can be considered as promising anticancer chemotherapeutic candidates. Copyright © 2022 Elsevier Ltd. All rights reserved.

Citation

Ksenia A Perevoshchikova, Elizaveta A Eshtukova-Shcheglova, Oleg V Markov, Andrey V Markov, Ivan V Chernikov, Mikhail A Maslov, Marina A Zenkova. Symmetric lipophilic polyamines exhibiting antitumor activity. Bioorganic & medicinal chemistry. 2022 Dec 15;76:117089